Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoglobulin Light-chain Amyloidosis × Cilengitide × Clear all

Sponsor

Conditions

Glioblastoma 4 Gliosarcoma 2 Brain Neoplasms 2 Recurrence 1 Prostatic Neoplasms 1 Optic Nerve Glioma 1 Oligodendroglioma 1 Neoplasms, Squamous Cell 1 Neoplasm Metastasis 1 Metatropic dwarfism 1 Carcinoma, Non-Small-Cell Lung 1 Astrocytoma 1

Interventions

Dexamethasone 15 Melphalan 13 Bortezomib 10 Calcium Dobesilate 7 Filgrastim 6 Granulocyte Colony-Stimulating Factor 5 birtamimab 4 Cyclophosphamide 4 dexamethasone acetate 3 Thalidomide 3 Peripheral Blood Stem Cell Transplantation 3 Lenalidomide 3 fludarabine phosphate 2 daratumumab 2 Whole-Body Irradiation 2 Mycophenolic Acid 2 Doxycycline 2 Darbepoetin alfa 2 Cyclosporine 2 Blood Component Removal 2 pomalidomide 1 pegfilgrastim 1 isatuximab 1 ferrous sulfate 1 ferric gluconate 1 dexamethasone 21-phosphate 1 carfilzomib 1 Therapeutics 1 Surveys and Questionnaires 1 Sucrose 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡